Back to search results

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma · Head and Neck Neoplasms · Head Cancer · Throat Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Cancer Clinical Trials Intake) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Ari Rosenberg)
Study leads

  • Ari Rosenberg, MD

    Principal Investigator

    University of Chicago

View source on ClinicalTrials.gov(opens in a new tab)